Interestingly, in tumors cells, YAP targets are enriched in Myc regulated genes (32), possibly suggesting that co-activation by YAP and Myc, while potentiating gene expression, may also render cancer cells liable to BET inhibitors and more in general to transcriptional inhibitors. Here, YAP1 is linked to cancer.